Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 1,445,900 shares at $0.08 ($105K) on 2010-11-22, disclosed to the SEC on 2010-11-24.
Open-market sale of $105k ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.07 | 45,000 | $3K | 3.0% |
| 2 | $0.07 | 292,000 | $20K | 19.4% |
| 3 | $0.07 | 440,000 | $31K | 29.2% |
| 4 | $0.08 | 5,000 | $400 | 0.4% |
| 5 | $0.07 | 118,000 | $8K | 7.8% |
| 6 | $0.07 | 4,900 |
| $343 |
| 0.3% |
| 7 | $0.07 | 115,000 | $8K | 7.6% |
| 8 | $0.07 | 17,000 | $1K | 1.1% |
| 9 | $0.08 | 215,250 | $17K | 16.3% |
| 10 | $0.08 | 3,750 | $300 | 0.3% |
| 11 | $0.08 | 10,000 | $800 | 0.8% |
| 12 | $0.08 | 75,000 | $6K | 5.7% |
| 13 | $0.08 | 105,000 | $8K | 8.0% |
| Total | $0.07 avg | 1,445,900 | $105K | 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |